Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does METHANDROSTENOLONE Cause Left ventricular hypertrophy? 5 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Left ventricular hypertrophy have been filed in association with METHANDROSTENOLONE. This represents 6.4% of all adverse event reports for METHANDROSTENOLONE.

5
Reports of Left ventricular hypertrophy with METHANDROSTENOLONE
6.4%
of all METHANDROSTENOLONE reports
4
Deaths
1
Hospitalizations

How Dangerous Is Left ventricular hypertrophy From METHANDROSTENOLONE?

Of the 5 reports, 4 (80.0%) resulted in death, 1 (20.0%) required hospitalization, and 3 (60.0%) were considered life-threatening.

Is Left ventricular hypertrophy Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for METHANDROSTENOLONE. However, 5 reports have been filed with the FAERS database.

What Other Side Effects Does METHANDROSTENOLONE Cause?

Drug abuse (48) Intentional product misuse (14) Multiple organ dysfunction syndrome (8) Acute kidney injury (7) Hepatic neoplasm (7) Hypertension (7) Intra-abdominal haemorrhage (7) Poisoning (7) Cardiac failure (6)

What Other Drugs Cause Left ventricular hypertrophy?

AMLODIPINE (158) CLOZAPINE (149) TACROLIMUS (135) FUROSEMIDE (128) PANTOPRAZOLE (117) BISOPROLOL (114) SACUBITRIL\VALSARTAN (105) ASPIRIN (104) ROSUVASTATIN (94) CARVEDILOL (87)

Related Pages

METHANDROSTENOLONE Full Profile All Left ventricular hypertrophy Reports All Drugs Causing Left ventricular hypertrophy METHANDROSTENOLONE Demographics